Clinical Development
New FDA Guidance: Developing Drugs and Biological Products for Weight Reduction
Medpace medical, regulatory, and biostatistics experts identify key differences between the FDA’s 2007 and 2025 guidance documents on developing products...
Company Spotlight
Medpace Expands Rare Disease & Metabolic Medical Leadership Team
Medpace is pleased to announce the addition of a new rare disease and metabolic expert, Dr. Loren Peña, to the medical leadership team.
Clinical Development
Medpace Recognizes World Obesity Day
March 4th is World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the...
Core Imaging Laboratory
Q&A with NASH Imaging Expert Dr. Mustafa Bashir
Medpace Imaging Core Laboratory, Associate Director, Dr. Scott Holland, had an opportunity to sit down with Dr. Bashir to discuss all things NASH imaging. In the…